176 related articles for article (PubMed ID: 34743390)
1. Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seeds.
Annadurai N; Malina L; Salmona M; Diomede L; Bastone A; Cagnotto A; Romeo M; Šrejber M; Berka K; Otyepka M; Hajdúch M; Das V
FEBS J; 2022 Apr; 289(7):1929-1949. PubMed ID: 34743390
[TBL] [Abstract][Full Text] [Related]
2. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
[TBL] [Abstract][Full Text] [Related]
3. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
4. What is the evidence that tau pathology spreads through prion-like propagation?
Mudher A; Colin M; Dujardin S; Medina M; Dewachter I; Alavi Naini SM; Mandelkow EM; Mandelkow E; Buée L; Goedert M; Brion JP
Acta Neuropathol Commun; 2017 Dec; 5(1):99. PubMed ID: 29258615
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
[TBL] [Abstract][Full Text] [Related]
6. Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain.
DeVos SL; Corjuc BT; Oakley DH; Nobuhara CK; Bannon RN; Chase A; Commins C; Gonzalez JA; Dooley PM; Frosch MP; Hyman BT
Front Neurosci; 2018; 12():267. PubMed ID: 29740275
[TBL] [Abstract][Full Text] [Related]
7. Trans-seeding of Alzheimer-related tau protein by a yeast prion.
Flach M; Leu C; Martinisi A; Skachokova Z; Frank S; Tolnay M; Stahlberg H; Winkler DT
Alzheimers Dement; 2022 Dec; 18(12):2481-2492. PubMed ID: 35142027
[TBL] [Abstract][Full Text] [Related]
8. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
9. Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells.
Annadurai N; Hrubý J; Kubíčková A; Malina L; Hajdúch M; Das V
Biochem Biophys Res Commun; 2023 Apr; 653():102-105. PubMed ID: 36863211
[TBL] [Abstract][Full Text] [Related]
10. Specific detection of tau seeding activity in Alzheimer's disease using rationally designed biosensor cells.
Lathuiliere A; Jo Y; Perbet R; Donahue C; Commins C; Quittot N; Fan Z; Bennett RE; Hyman BT
Mol Neurodegener; 2023 Aug; 18(1):53. PubMed ID: 37553663
[TBL] [Abstract][Full Text] [Related]
11. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
[TBL] [Abstract][Full Text] [Related]
12. Proteopathic tau seeding predicts tauopathy in vivo.
Holmes BB; Furman JL; Mahan TE; Yamasaki TR; Mirbaha H; Eades WC; Belaygorod L; Cairns NJ; Holtzman DM; Diamond MI
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4376-85. PubMed ID: 25261551
[TBL] [Abstract][Full Text] [Related]
13. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
[TBL] [Abstract][Full Text] [Related]
14. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
16. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
17. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
[TBL] [Abstract][Full Text] [Related]
18. Tau seeding without tauopathy.
LaCroix MS; Artikis E; Hitt BD; Beaver JD; Estill-Terpack SJ; Gleason K; Tamminga CA; Evers BM; White CL; Caughey B; Diamond MI
J Biol Chem; 2024 Jan; 300(1):105545. PubMed ID: 38072056
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive tau biosensor cells detect no seeding in Alzheimer's disease CSF.
Hitt BD; Vaquer-Alicea J; Manon VA; Beaver JD; Kashmer OM; Garcia JN; Diamond MI
Acta Neuropathol Commun; 2021 May; 9(1):99. PubMed ID: 34039426
[TBL] [Abstract][Full Text] [Related]
20. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
